Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Change in Cash (2016 - 2017)

Bone Biologics has reported Change in Cash over the past 2 years, most recently at -$931700.0 for Q4 2017.

  • Quarterly Change in Cash fell 1273.01% to -$931700.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $69904.0 through Dec 2017, up 114.13% year-over-year, with the annual reading at $2.0 million for FY2025, 572.96% up from the prior year.
  • Change in Cash was -$931700.0 for Q4 2017 at Bone Biologics, down from $838965.0 in the prior quarter.
  • Over five years, Change in Cash peaked at $3.1 million in Q1 2016 and troughed at -$2.0 million in Q2 2016.